• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AXP
Click for more information
0.00% 0.2¢

AXP ENERGY LIMITED - Announcements

Market Cap $5.824M  ! watchlist Created with Sketch. Add to my watchlist

AXP Energy Ltd. is an oil and gas production and development company. The Company’s... AXP Energy Ltd. is an oil and gas production and development company. The Company’s segments are defined by geographic area within its Oil & Gas basins in the United States: Appalachian Basin, Denver-Julesburg Basin, Illinois Basin, and Corporate and other. The Appalachian Basin is situated primarily in the Eastern part of Kentucky, Western Virginia and North-Eastern part of Tennessee; these assets are situated in a well-defined gas producing area of the Appalachian Basin. The Denver-Julesburg Basin assets are situated in the historic Florence oilfield and are geologically defined by the Canon City Embayment. The Illinois Basin is spread across Western Kentucky, situated in the heart and prolific section of the basin. Its formations of interest include the Palestine, Waltersburg, Tar Springs, Hardinsburg, Jackson, St. Genevieve, O’Hara, McClosky, Warsaw and Fort Payne. The Company has primary operations in Kentucky, Illinois, Indiana and Colorado.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AXP Appendix 3B24/02/16
AXP Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
AXP Quarterly Investor Newsletter - December 201517/12/15
AXP AirXpanders to use de novo process for AeroFormPRICE SENSITIVE13/11/15
AXP Appendix 4C - quarterlyPRICE SENSITIVE29/10/15
AXP Appendix 3B22/10/15
AXP AirXpanders presents successful XPAND pivotal trial dataPRICE SENSITIVE20/10/15
AXP AeroForm Australian Launch UpdatePRICE SENSITIVE07/10/15
AXP Appendix 3B30/09/15
AXP Appendix 3B14/09/15
AXP AirXpanders Half Year Results Conference Call Recording01/09/15
AXP AirXpanders submits FDA 510(k) filing for AeroFormPRICE SENSITIVE01/09/15
AXP Release of Securities from Escrow31/08/15
AXP Appendix 4D and Half Year Financial ResultsPRICE SENSITIVE31/08/15
AXP AirXpanders XPAND Pivotal Trial Meets Primary EndpointPRICE SENSITIVE25/08/15
AXP Quarterly Investor Newsletter21/08/15
AXP Release of Securities from Escrow14/08/15
AXP Revised Appendix 3B12/08/15
AXP Appendix 3B07/08/15
AXP Appendix 4C - quarterlyPRICE SENSITIVE29/07/15
AXP Appendix 3X T Shalon26/06/15
AXP Appendix 3X S Dodson26/06/15
AXP Appendix 3X D Condon26/06/15
AXP Appendix 3X B Smith26/06/15
AXP Appendix 3X B Cheskin26/06/15
AXP Appendix 3X A Cha26/06/15
AXP Substantial Shareholding Notice24/06/15
AXP Audited Accounts for full year ended 31 Dec 201419/06/15
AXP Audited Accounts for full year ended 31 Dec 201319/06/15
AXP Audited Accounts for full year ended 31 Dec 201219/06/15
AXP Securities Trading Policy19/06/15
AXP Full terms of the 2015 Equity Incentive Plan19/06/15
AXP Corporate Governance Statement19/06/15
AXP Full terms of the 2005 Equity Incentive Plan19/06/15
AXP Amended and Restated By-laws19/06/15
AXP Amended and Restated Certificate of Incorporation19/06/15
AXP Prospectus19/06/15
AXP Information Form and Checklist Annexure III19/06/15
AXP Information Form and Checklist19/06/15
AXP Appendix 1A19/06/15
AXP Pre-quotation disclosure19/06/15
AXP ASX Market Release - Pre-quotation disclosurePRICE SENSITIVE19/06/15
AXP ASX Notice - Admission and Quotation19/06/15
AXP ASX Market Release - Admission to Official ListPRICE SENSITIVE19/06/15
AXP Appendix 3B
24/02/16
AXP Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
AXP Quarterly Investor Newsletter - December 2015
17/12/15
AXP AirXpanders to use de novo process for AeroForm
13/11/15PRICE SENSITIVE
AXP Appendix 4C - quarterly
29/10/15PRICE SENSITIVE
AXP Appendix 3B
22/10/15
AXP AirXpanders presents successful XPAND pivotal trial data
20/10/15PRICE SENSITIVE
AXP AeroForm Australian Launch Update
07/10/15PRICE SENSITIVE
AXP Appendix 3B
30/09/15
AXP Appendix 3B
14/09/15
AXP AirXpanders Half Year Results Conference Call Recording
01/09/15
AXP AirXpanders submits FDA 510(k) filing for AeroForm
01/09/15PRICE SENSITIVE
AXP Release of Securities from Escrow
31/08/15
AXP Appendix 4D and Half Year Financial Results
31/08/15PRICE SENSITIVE
AXP AirXpanders XPAND Pivotal Trial Meets Primary Endpoint
25/08/15PRICE SENSITIVE
AXP Quarterly Investor Newsletter
21/08/15
AXP Release of Securities from Escrow
14/08/15
AXP Revised Appendix 3B
12/08/15
AXP Appendix 3B
07/08/15
AXP Appendix 4C - quarterly
29/07/15PRICE SENSITIVE
AXP Appendix 3X T Shalon
26/06/15
AXP Appendix 3X S Dodson
26/06/15
AXP Appendix 3X D Condon
26/06/15
AXP Appendix 3X B Smith
26/06/15
AXP Appendix 3X B Cheskin
26/06/15
AXP Appendix 3X A Cha
26/06/15
AXP Substantial Shareholding Notice
24/06/15
AXP Audited Accounts for full year ended 31 Dec 2014
19/06/15
AXP Audited Accounts for full year ended 31 Dec 2013
19/06/15
AXP Audited Accounts for full year ended 31 Dec 2012
19/06/15
AXP Securities Trading Policy
19/06/15
AXP Full terms of the 2015 Equity Incentive Plan
19/06/15
AXP Corporate Governance Statement
19/06/15
AXP Full terms of the 2005 Equity Incentive Plan
19/06/15
AXP Amended and Restated By-laws
19/06/15
AXP Amended and Restated Certificate of Incorporation
19/06/15
AXP Prospectus
19/06/15
AXP Information Form and Checklist Annexure III
19/06/15
AXP Information Form and Checklist
19/06/15
AXP Appendix 1A
19/06/15
AXP Pre-quotation disclosure
19/06/15
AXP ASX Market Release - Pre-quotation disclosure
19/06/15PRICE SENSITIVE
AXP ASX Notice - Admission and Quotation
19/06/15
AXP ASX Market Release - Admission to Official List
19/06/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.824M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
33 42453992 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 88974573 57
View Market Depth
Last trade - 16.12pm 22/11/2024 (20 minute delay) ?
AXP (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.